HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$4.92
Day range
$4.85 - $5.75
Year range
$4.20 - $28.60
Market cap
7.14M USD
Avg Volume
136.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.15M | 25.40% |
Net income | -3.22M | -32.39% |
Net profit margin | — | — |
Earnings per share | -5.61 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.07M | -63.12% |
Total assets | 4.36M | -47.67% |
Total liabilities | 5.76M | 461.15% |
Total equity | -1.41M | — |
Shares outstanding | 1.32M | — |
Price to book | -2.46 | — |
Return on assets | -200.08% | — |
Return on capital | -7,191.78% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.22M | -32.39% |
Cash from operations | -514.00K | 75.08% |
Cash from investing | — | — |
Cash from financing | 1.82M | — |
Net change in cash | 1.32M | 520.38% |
Free cash flow | 777.25K | 167.88% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
5
